213 studies found for:    Open Studies | "Psoriasis"
Show Display Options
Rank Status Study
21 Recruiting Vascular Inflammation in Psoriasis-Ustekinumab (VIP-U)
Conditions: Psoriasis;   Cardiovascular Disease
Interventions: Drug: Ustekinumab;   Drug: Placebo
22 Not yet recruiting The Effect of Riboflavin on Moderate to Severe Plaque Type Psoriasis
Condition: Psoriasis
Interventions: Dietary Supplement: Riboflavin;   Other: Placebo
23 Recruiting Serum, Cellular and Imaging Markers of Arthritis in Psoriasis Patients
Condition: Psoriasis
Intervention:
24 Unknown  TNF-alfa Inhibitors and Antibody Production in Patients With Psoriasis
Condition: Psoriasis
Intervention: Drug: subjects will receive either infliximab, adalimumab or etanercept
25 Unknown  The Impact of Targeted Therapy on Microorganism in Patients With Psoriasis
Condition: Psoriasis
Intervention:
26 Unknown  Effect of GLP-1 Analogs on Psoriasis in Type 2 Diabetic Patients
Conditions: Type 2 Diabetes;   Psoriasis
Intervention: Drug: GLP-1 analog
27 Unknown  The Effect of Alga Dunaliella Bardawil on Psoriasis
Condition: Psoriasis
Interventions: Dietary Supplement: Alga Dunaliella Bardawil placebo;   Dietary Supplement: Dunaliella Bardawil
28 Unknown  UVB-311nm After Initial Slow Response to Adalimumab in Psoriasis
Condition: Psoriasis
Interventions: Radiation: UVB-311nm;   Other: No treatment
29 Recruiting Secukinumab in TNF-IR Psoriasis Patients.
Condition: Psoriasis
Interventions: Biological: Secukinumab 150 mg;   Biological: Secukinumab 300 mg
30 Unknown  A Study of Topical Indigo Naturalis Treatment in Patients With Mild to Moderate Plaque-type Psoriasis
Condition: Psoriasis
Interventions: Drug: Indigo Naturalis;   Drug: Placebo
31 Not yet recruiting Observational Study of Apremilast in Patients With Psoriasis in The Netherlands
Condition: Psoriasis
Intervention:
32 Not yet recruiting Assessing the Efficacy and Safety of Metformin in Treatment of Moderate Psoriasis
Condition: Psoriasis
Interventions: Drug: Metformin;   Drug: Placebo;   Drug: Topical Coal tar;   Drug: Topical calcipotriol
33 Recruiting Canadian Humira Post Marketing Observational Epidemiological Study: Assessing Effectiveness in Psoriasis
Condition: Psoriasis
Intervention:
34 Not yet recruiting ASIS for Enbrel in Plaque Psoriasis
Condition: Plaque Psoriasis.
Interventions: Drug: Gadolinium;   Drug: Efficacy of Enbrel subcutaneously at Week 12;   Drug: Efficacy of Enbrel subcutaneously at Week 24;   Drug: Efficacy of Enbrel subcutaneously at Week 36;   Drug: Efficacy of Enbrel subdermally at Week 12;   Drug: Efficacy of Enbrel subdermally at Week 24;   Drug: Efficacy of Enbrel subdermally at Week 36;   Drug: PASI 75 n(%) subcutaneously at Week 12;   Drug: PASI 75 n(%) subcutaneously at Week 24;   Drug: PASI 75 n(%) subcutaneously at Week 36;   Drug: PASI 75 n(%) subdermally at Week 12;   Drug: PASI 75 n(%) subdermally at Week 24;   Drug: PASI 75 n(%) subdermally at Week 36;   Drug: Adverse Reactions of Enbrel subcutaneously;   Drug: Adverse Reactions of Enbrel subdermally at Week 36
35 Recruiting Serum Lipid Levels and Other Biomarkers of Cardiovascular Disease in Patients With Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Dyslipidemia
Intervention:
36 Unknown  The Influence of Adalimumab on Cardiovascular and Metabolic Risk in Psoriasis
Conditions: Psoriasis;   Cardiovascular Diseases;   Diabetes Mellitus, Type 2
Interventions: Drug: Adalimumab treatment arm;   Drug: Fumaric acid esters treatment group;   Other: Narrow band UVB radiation
37 Recruiting Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris
Condition: Psoriasis
Interventions: Biological: Ustekinumab;   Biological: Abatacept;   Procedure: Placebo for Ustekinumab;   Drug: Placebo for Abatacept
38 Recruiting A Study of Otezla® in Patients With Plaque Psoriasis Under Routine Conditions
Condition: Psoriasis
Intervention:
39 Recruiting A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis
Condition: Psoriasis
Interventions: Drug: GSK2894512 1% Cream;   Drug: GSK2894512 0.5% Cream;   Drug: Vehicle cream
40 Unknown  Cross-sectional Evaluation of Biological Markers of Cardiovascular Disease in Children and Adolescents With Psoriasis
Conditions: Psoriasis;   Obesity;   Cardiovascular Risk;   Inflammation
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years